维普期刊资源整合服务平台（V6.5）

61篇 您的检索式：作者名="Muu"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Terminal complementinhibitor eculizumab in atypical hemolytic-uremicsyndrome显示文摘	Legendre CM Licht C Muus P	2013	N Engl J Med2013，368，23：	1
2	The terminal complement inhibitor Eculizumab reduces thrombosis in patients with paroxysmal nocturnal hemoglobinuria显示文摘	Hillmen P Muus P Duhrsen U	2006	Blood2006，，108：	1
3	Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics ofbarasertib(AZDll52) in patients with advanced acute myeloid leukemia显示文摘	Lowenberg B Muus P Ossenkoppele G	2011	Blood2011，118，23：	1
4	Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies 显示文摘	Licht C Greenbaum LA Muus P	2015	Kidney International2015，87，5：	1
5	Generalized projection method for non-Lipschitz mukivalued monotone variational inequalities显示文摘	Anh P N Muu L D Strodiot J	2009	Acta Math Vietnam2009，34，1：	1
6	Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission 显示文摘	Jerjis S Roovers E Muus P	1998	Bone Marrow Transplant1998，22，1：	1
7	MMosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells 显示文摘	Kroef M J Bolk MJ Muus P	1997	Leukemia1997，11，4：	1
8	Cyclosporin increases celluar idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance显示文摘	Smeets M Raymakers R Muus P	2001	Leukemia2001，15，1：	1
9	Detection of hidden shot balls in a gas-cooled turbine blade with an NRT gadolinium tagging method显示文摘	Sim Cheul Muu Kim Yi Kyung Kim TaeJoo	2009	Nucl Instru and Meths in Phys Res2009，605，：	1
10	Validation of the Stroke Specific Quality of Life Scale (SS-QOL) :test of reliability and validity of the Danish version (SS-QOL-DK) 显示文摘	Muus I Williams LS Ringsberg KC	2007	Clin Rchabil2007，21，7：	1
11	A global optimization method for solving convex quadratic bilevel programming problems显示文摘	Muu L D Quy N V	2003	Journal of Global Optimization2003，26，2：	1
12	Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria显示文摘	Van Bijnen ST Van Heerde WL Muus P	2012	J Thromb Haemost2012，10，：	1
13	A global optimizatioa method for solving convex quadratic bilevel programming problems 显示文摘	Muu L D Quy N V	2003	Journal of Global Optimization2003，26，2：	1
14	Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome 显示文摘	de Witte T Oosterveld M Muus P	2007	Blood Rev2007，21，：	1
15	Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome显示文摘	Legendre CM Licht C Muus P	2013	N Engl J Med2013，368，23：	1
16	Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia显示文摘	Witte TD Muus P Pauw BD	1990	Cancer1990，66，5：	1
17	Health-related quality of life after stroke reliability of proxy responses显示文摘	Muus I Petzold M Ringsberg KC	2009	Clinical Nursing Research2009，18，2：	1
18	Ph- ase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia 显示文摘	LOWENBERG B MUUS P OSS ENKOPPELE G	2011	Blood2011，118，23：	1
19	Simplified modeling of phosphorus removal by vegetative filter strips to control runoff pollution from phosphate mining areas显示文摘	KUO Y M MUU(N)OZ-CARPEN		0，，：	1
20	Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute mye- logenous leukemia(AML) or high-risk myelodysplastic syndrome (HR-MDS) : phase I results of an ongoing phase I / U study of the leukemia groups of EORTC and GIMEMA(EORTC GIMEMA 06061/AML-14A trial)显示文摘	Willemze R Suciu S Muus P	2014	Ann Hematol2014，93，6：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示